Jet nebulising systems for recombinant human DNase I.
AUTOR(ES)
Hung, J C
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1030101Documentos Relacionados
- Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
- Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.
- In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
- Sequence-dependent structural variations of DNA revealed by DNase I.
- Engineering actin-resistant human DNase I for treatment of cystic fibrosis.